Clinical Trials Logo

Acute Cerebral Ischemia clinical trials

View clinical trials related to Acute Cerebral Ischemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT05955326 Recruiting - Clinical trials for Acute Cerebral Ischemia

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Start date: January 8, 2024
Phase: Phase 4
Study type: Interventional

This is a prospective, multicenter, randomized, double-blind, parallel, phase IV study designed to evaluate the safety and efficacy of sovateltide (PMZ-1620, IRL-1620) as a potential treatment for cerebral ischemic stroke.

NCT ID: NCT02315443 Completed - Clinical trials for Acute Cerebral Ischemia

Field Randomization of Nerinetide (NA-1) Therapy in Early Responders

FRONTIER
Start date: March 26, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether nerinetide (NA-1) is effective in reducing global disability in patients with acute cerebral ischemia if administered early after symptom onset.

NCT ID: NCT01378000 Completed - Clinical trials for Acute Cerebral Ischemia

Study on Continuous Intravenous of Unfractionated Heparin (UFH) to Treat Progressive Cerebral Infarction

UHPCI
Start date: October 2009
Phase:
Study type: Observational

A clinical trial to study the effects of dosage, infusion methods and complications of unfractionated heparin (UFH) treating acute progressive cerebral infraction was conducted. In this study, we observed the effects of four UFH treatments on 480 acute progressive cerebral infraction patients during from the 6th and the 72nd hour after the attack. It was concluded that the ultra-slow continuous intravenous infusion of UFH can significantly reduce the neurological deficit score of patients with progressive cerebral infarction, increase the cure rate, decrease the recurrence rate, and improve long-term quality of daily life. It is more effective than the treatment of intravenous infusion of low- molecular- weight UFH at once a day, and the risk of bleeding may not necessarily be increased.

NCT ID: NCT00472381 Completed - Acute Stroke Clinical Trials

Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke

INSULINFARCT
Start date: May 2007
Phase: Phase 2/Phase 3
Study type: Interventional

Hyperglycaemia is a frequent finding in acute ischemic stroke and associated with poor outcome. But the modalities of glucose lowering are still debated. This study will test the efficacy and safety of continuous intravenous insulin protocol versus usual subcutaneous insulin in acute ischemic stroke.